Immunocellular Therapeutics’ work in industry-leading, next-generation cancer vaccine immunotherapies
Meta Description
ImmunoCellular Therapeutics, Ltd. (NYSE MKT: IMUC) is an emerging leader in the research, development and commercialization of novel cancer vaccine immunotherapies for the treatment brain, ovarian and other solid tumors.